CIHR has announced the results of the second round of funding through the Clinical Trials Fund and Canada’s Strategy for Patient-Oriented Research: $43.1M will be distributed to 14 new clinical trials projects. This funding will be used to assess treatments, diagnostic tests, and prevention tools for health concerns that range from sepsis to the flu. The recipients include researchers from Dalhousie University, Queen’s University, the University of Alberta, the University of Calgary, and the University of Manitoba. “CIHR is proud to support 14 innovative clinical trials testing ground-breaking treatments and tools to protect people living in Canada from significant threats to our health,” said CIHR Acting President Dr Tammy Clifford.